| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |